JP2009503083A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503083A5
JP2009503083A5 JP2008525073A JP2008525073A JP2009503083A5 JP 2009503083 A5 JP2009503083 A5 JP 2009503083A5 JP 2008525073 A JP2008525073 A JP 2008525073A JP 2008525073 A JP2008525073 A JP 2008525073A JP 2009503083 A5 JP2009503083 A5 JP 2009503083A5
Authority
JP
Japan
Prior art keywords
alkyl
methyl
aryl
oxo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008525073A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503083A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/029652 external-priority patent/WO2007019101A2/en
Publication of JP2009503083A publication Critical patent/JP2009503083A/ja
Publication of JP2009503083A5 publication Critical patent/JP2009503083A5/ja
Pending legal-status Critical Current

Links

JP2008525073A 2005-08-04 2006-07-28 Hivインテグラーゼ阻害薬 Pending JP2009503083A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70532805P 2005-08-04 2005-08-04
PCT/US2006/029652 WO2007019101A2 (en) 2005-08-04 2006-07-28 Hiv integrase inhibitors

Publications (2)

Publication Number Publication Date
JP2009503083A JP2009503083A (ja) 2009-01-29
JP2009503083A5 true JP2009503083A5 (enExample) 2009-09-10

Family

ID=37727849

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008525073A Pending JP2009503083A (ja) 2005-08-04 2006-07-28 Hivインテグラーゼ阻害薬

Country Status (4)

Country Link
US (1) US20080214503A1 (enExample)
EP (1) EP1910356A4 (enExample)
JP (1) JP2009503083A (enExample)
WO (1) WO2007019101A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010011959A1 (en) * 2008-07-25 2010-01-28 Gilead Sciences, Inc. Antiviral compounds
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
WO2014047562A2 (en) * 2012-09-21 2014-03-27 Epiphany Biosciences Method of treating and/or preventing shingles and method of treating and/or preventing zoster associated pain
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225318B1 (en) * 1996-10-17 2001-05-01 Pfizer Inc 4-aminoquinazolone derivatives
AU1532802A (en) * 2000-10-12 2002-04-22 Merck & Co Inc Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
ATE430745T1 (de) * 2000-10-12 2009-05-15 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
ES2291642T3 (es) * 2002-01-17 2008-03-01 MERCK & CO., INC. Hidroxinaftiridinoncarboxamidas utiles como inhibidores de la integrasa de vih.
DE60322920D1 (de) * 2002-08-13 2008-09-25 Shionogi & Co Heterocyclische verbindungen mit hiv-integrase-hemmender wirkung
TW200505902A (en) * 2003-03-20 2005-02-16 Schering Corp Cannabinoid receptor ligands
WO2005028478A1 (en) * 2003-09-19 2005-03-31 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
EP1720856B1 (en) * 2004-02-11 2013-08-14 GlaxoSmithKline LLC Hiv integrase inhibitors

Similar Documents

Publication Publication Date Title
JP2013544276A5 (enExample)
JP2007517807A5 (enExample)
JP2018502101A5 (enExample)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2013532652A5 (enExample)
JP2014500295A5 (enExample)
JP2006524660A5 (enExample)
RU2005123485A (ru) Производные фосфонооксихиназолина и их фармацевтическое применение
JP2009504763A5 (enExample)
JP2013509392A5 (enExample)
JP2010529147A5 (enExample)
RU2011136537A (ru) Кристаллическая форма (r)-3-(4-(2-метилтетразол-5-ил)пиридин-5-ил)-3-фторфенил)-5-гидроксиметил оксазолидин-2-он диводород фосфата
JP2006501201A5 (enExample)
JP2008535803A5 (enExample)
JP2012510502A5 (enExample)
JP2011505347A5 (enExample)
JP2010513434A5 (enExample)
JP2011507896A5 (enExample)
JP2009538910A5 (enExample)
JP2014500265A5 (enExample)
JP2007507494A5 (enExample)
RU2004100843A (ru) Производные имидазола, модулирующие натриевые каналы
JP2004532240A5 (enExample)
JP2002505286A5 (enExample)
JP2018530582A5 (enExample)